Logo

American Heart Association

  109
  0


Final ID: Sa2153

Detecting Myosteatosis-Related Low Physical Function in Heart Failure Patients Using Abdominal Computed Tomography and Plasma Amino Acid Profile

Abstract Body (Do not enter title and authors here): Background: Evaluation of sarcopenia requires quantifying appendicular skeletal muscle mass and functional capacity, but resource constraints often limit feasibility. Alterations in muscle quality, especially intramuscular lipid infiltration (i.e., myosteatosis), and systemic metabolic derangements are associated with disability.
Hypothesis: Opportunistic CT imaging and plasma amino acid profiling could identify low physical function in patients with heart failure (HF).
Methods: We retrospectively examined 220 HF patients (74 ± 13 years old; 59% male) who underwent plasma amino acid profiling, abdominal CT imaging, and dual-energy X-ray absorptiometry (DXA) scan within two months. Myosteatosis was evaluated using single-slice CT imaging at the L3/4 level and quantified as mean muscle attenuation (MMA). Physical function was assessed by the short physical performance battery (SPPB), with low physical function defined as SPPB ≤9.
Results: CT-derived single-slice areas of skeletal muscle and adipose tissue were highly correlated with DXA-derived appendicular skeletal muscle mass and total fat mass. Logistic regression analyses revealed that higher age and lower MMA, but not skeletal muscle area, were significantly associated with low physical function independently of NT-proBNP. Subjects with MMA below the median value (32.0 HU for males and 23.7 HU for females) had higher odds of low physical function (adjusted OR 2.04, 95% CI 1.04-3.96). Ten amino acids and the Fischer ratio were significantly correlated with MMA levels. Multivariate regression analyses, adjusted for potential confounders including age, gender, and body mass index, demonstrated that serum albumin and Fischer ratio were independent determinants of MMA levels. When serum albumin and Fischer ratio were dichotomized by their median values (3.6 mg/dL and 3.23, respectively), the prevalence of low physical function was significantly higher in subjects with low albumin and low Fischer ratio, but not in those with low levels of only either parameter, compared to those with high albumin and high Fischer ratio (adjusted OR 2.36, 95% CI 1.02-5.49).
Conclusions: Myosteatosis assessed by single-slice abdominal CT imaging is an independent determinant of low physical function in HF patients. Combined with an assessment of serum albumin and Fischer ratio, these simple biomarkers could facilitate the early detection of patients at risk for developing frailty.
  • Kawaharata, Wataru  ( Sapporo Medical University School of Medicine , Sapporo , Japan )
  • Nishikawa, Ryo  ( Sapporo Medical University School of Medicine , Sapporo , Japan )
  • Fujito, Takefumi  ( Sapporo Medical University School of Medicine , Sapporo , Japan )
  • Nobutaka, Nagano  ( Sapporo Medical University School of Medicine , Sapporo , Japan )
  • Furuhashi, Masato  ( Sapporo Medical University School of Medicine , Sapporo , Japan )
  • Kouzu, Hidemichi  ( Sapporo Medical University School of Medicine , Sapporo , Japan )
  • Ogura, Keishi  ( Sapporo Medical University Hospital , Sapporo , Japan )
  • Yano, Toshiyuki  ( Sapporo Medical University School of Medicine , Sapporo , Japan )
  • Katano, Satoshi  ( Sapporo Medical University Hospital , Sapporo , Japan )
  • Nagaoka, Ryohei  ( Sapporo Medical University Hospital , Sapporo , Japan )
  • Numazawa, Ryo  ( Sapporo Medical University Hospital , Sapporo , Japan )
  • Yamano, Kotaro  ( Sapporo Medical University Hospital , Sapporo , Japan )
  • Ohori, Katsuhiko  ( Sapporo Medical University School of Medicine , Sapporo , Japan )
  • Author Disclosures:
    Wataru Kawaharata: DO NOT have relevant financial relationships | Ryo Nishikawa: No Answer | Takefumi Fujito: No Answer | Nagano Nobutaka: No Answer | Masato Furuhashi: No Answer | Hidemichi Kouzu: DO NOT have relevant financial relationships | Keishi Ogura: No Answer | Toshiyuki Yano: No Answer | Satoshi Katano: No Answer | Ryohei Nagaoka: No Answer | Ryo Numazawa: No Answer | Kotaro Yamano: DO NOT have relevant financial relationships | Katsuhiko Ohori: No Answer
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Heart Failure Potpourri 2.4

Saturday, 11/16/2024 , 10:30AM - 11:30AM

Abstract Poster Session

More abstracts on this topic:
Cardiogenic Shock Patients Achieving Native Heart Survival With Impella 5.5 Support Still Experience Significant Skeletal Muscle Loss

Adamian Robert, Fowler Jeffrey, Smith Anson, Thorngren Christina, Sriwattanakomen Roy, Keebler Mary, Wolfe Jonathan, Hickey Gavin, Hopkins Steven, Zawadzki Jonathan, Barnes Alexis, Crane Alex, Klass Wyatt, Rhinehart Zachary, Murray Holt, Toma Catalin

18F-FDG PET/CT Evaluation of Incidental Extracardiac CT Findings on 82Rb-Chloride PET Myocardial Perfusion Imaging

Dhaliwal Jasmeet, David Sthuthi, Puente Cesar, Nandakumar Menon, Sayre James, Zhong Jin, Berenji Gholam, Packard Rene

You have to be authorized to contact abstract author. Please, Login
Not Available